Publications

Anemia, a prevalent hematologic manifestation in individuals living with HumanImmunodeficiency Virus (HIV) infection, has garnered considerable attention as a prognosticindicator for disease progression and adverse clinical outcomes. This abstract presents acomprehensive review elucidating the intricate relationship between anemia and theprogression of HIV infection, incorporating epidemiological trends, underlyingpathophysiological mechanisms, clinical implications, and prognostic significance. Despiteadvances in antiretroviral therapy (ART), anemia remains a frequent complication in HIVinfectedindividuals, posing substantial challenges to patient management. This paper aimsto provide a nuanced understanding of anemia's role as a prognostic marker, surpassing itsconventional characterization as a hematologic abnormality in the context of HIV infection.Anemia's role as a predictive marker for adverse clinical outcomes in HIV patients isexplored, encompassing increased mortality rates, heightened risk of opportunisticinfections, accelerated disease progression, and compromised quality of life. The reviewdelves into its prognostic significance, shaping therapeutic decisions and prognosticassessments. This paper encapsulates the criticality of anemia as a prognostic marker fordisease progression in HIV infection. Understanding its epidemiology, pathophysiologicalmechanisms, clinical implications, and prognostic significance is pivotal for informedclinical decision-making, prognostic assessments, and optimizing care paradigms in HIVmanagement.Keywords: Anemia, Prognostic Marker, Disease Progression and HIV